You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

International Prognostic Scoring System

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Oral Azacitidine
    • Placebo for Oral Azacitidine
    • Buenos Aires, Argentina
    • +1 more
    Aug 1, 2022

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    MDS and Allogeneic Stem Cell Transplantation Trial in Perugia (MDS and AlloHSCT)

    Recruiting
    • MDS and Allogeneic Stem Cell Transplantation
    • MDS and AlloHSCT
    • Perugia, PG, Italy
      University of Perugia
    Mar 11, 2021

    Validate Difficulty Scoring System and DevelopNovel Scoring

    Enrolling by invitation
    • Liver Diseases
    • Minimally Invasive Liver Resection
    • Dallas, Texas
      Liver Institute of Methodist Dallas Medical Center
    Dec 20, 2022

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    MDS Trial in France, Germany, United States (Oral rigosertib)

    Completed
    • Myelodysplastic Syndromes
    • Oral rigosertib
    • Stanford, California
    • +13 more
    Jun 15, 2021

    Myelodysplastic Syndrome Trial in New York (rigosertib)

    Withdrawn
    • Myelodysplastic Syndrome
    • New York, New York
      Columbia University Medical Center
    Jun 29, 2020

    Molecular Signature for Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • Diagnostic assistance tool
    • (no location specified)
    Feb 2, 2023

    CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

    Active, not recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • DISEASE
    • (no location specified)
    May 4, 2023

    Pediatric GCS-Pupil Score in Pediatric Traumatic Brain Injury

    Not yet recruiting
    • Brain Injuries, Traumatic
    • Glasgow coma scale
    • Bursa, Turkey
      Bursa Provincial Health Directorate University of Health Science
    Jun 16, 2022

    Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

    Recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
      • Milan, Italy
        Ospedale San Raffaele
      Aug 29, 2023

      MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Luspatercept
      • Epoetin Alfa
      • Concord, California
      • +100 more
      Jul 20, 2023

      Ovarian Cancer Individualized Scoring System Scoring System

      Not yet recruiting
      • Ovarian Cancer
        • Alexandria, Egypt
        • +1 more
        Aug 9, 2022

        Upper GI Bleeding Trial in Sohag (history taking , vital signs and labaratory investigations)

        Recruiting
        • Upper GI Bleeding
        • history taking , vital signs and labaratory investigations
        • Sohag, Egypt
          Sohag University hospitals
        May 17, 2023

        Vulvar Cancer Individualized Scoring System (VCISS)

        Not yet recruiting
        • Vulvar Cancer
        • Machine learning-based prediction model
        • Alexandria, Egypt
        • +1 more
        Aug 22, 2023

        Laparoscopic Splenectomy, Children, Benign Blood Diseases Trial (laparoscopic splenectomy)

        Completed
        • Laparoscopic Splenectomy
        • +2 more
        • laparoscopic splenectomy
        • (no location specified)
        Feb 19, 2021

        Epidemiological and Clinical-pathological Factors of

        Completed
        • Myeloproliferative Neoplasm
        • +4 more
          • Guayaquil, Guayas, Ecuador
            Sociedad de Lucha Contra el Cáncer
          Apr 25, 2023

          GENOMED4ALL: Improving MDS Classification and Prognosis by AI

          Active, not recruiting
          • Myelodysplastic Syndromes
            • Milano, Italy
              Istituto Clinico Humanitas
            Jun 28, 2021

            The New ICU Prognostic Score APACHE-INf

            Recruiting
            • Intensive Care Unit
            • +2 more
            • Prognosis Scoring
            • Nilüfer, Bursa, Turkey
              University of Health Sciences, Bursa Sehir Training & Research H
            Jul 13, 2023

            MDS Trial (Decitabine/Cedazuridine, Magrolimab)

            Not yet recruiting
            • Myelodysplastic Syndromes
            • (no location specified)
            Apr 18, 2023

            Ruxolitinib in Patients With Myelofibrosis

            Not yet recruiting
            • Myelofibrosis
            • (no location specified)
            Feb 28, 2023

            MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

            Active, not recruiting
            • Myelodysplastic Syndromes
            • Magrolimab
            • +2 more
            • Birmingham, Alabama
            • +168 more
            Dec 7, 2022

            Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

            Recruiting
            • Primary Myelofibrosis
            • +2 more
            • Worcester, Massachusetts
            • +16 more
            Oct 31, 2022

            Septate Uterus Trial in Cairo (Shawki Septum Scoring System, ESHRE ASRM Classification)

            Recruiting
            • Septate Uterus
            • Shawki Septum Scoring System
            • ESHRE ASRM Classification
            • Cairo, Egypt
              Shifa Hospital
            Apr 8, 2023